Cargando…

Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis

BACKGROUND: Hypoalbuminemia has been reported in COVID-19 patients. Exploring the influencing factors and possible adverse consequences of albumin reduction may provide some guidance for the treatment of COVID-19 patients. METHODS: In this multicentre retrospective study, we collected information in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chaoyue, Zhang, Ying, Zhao, Xi, Tao, Meihui, Yan, Wei, Fu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437137/
https://www.ncbi.nlm.nih.gov/pubmed/34526790
http://dx.doi.org/10.2147/IDR.S327090
_version_ 1783752114778931200
author Chen, Chaoyue
Zhang, Ying
Zhao, Xi
Tao, Meihui
Yan, Wei
Fu, Yu
author_facet Chen, Chaoyue
Zhang, Ying
Zhao, Xi
Tao, Meihui
Yan, Wei
Fu, Yu
author_sort Chen, Chaoyue
collection PubMed
description BACKGROUND: Hypoalbuminemia has been reported in COVID-19 patients. Exploring the influencing factors and possible adverse consequences of albumin reduction may provide some guidance for the treatment of COVID-19 patients. METHODS: In this multicentre retrospective study, we collected information including demographics, comorbidities, clinical symptoms, complications, laboratory tests, treatment, and outcomes of patients diagnosed with COVID-19 from three hospitals in Wuhan, China. We compared the indexes between patients with hypoalbuminemia and normal albumin. Regression model was used to evaluate various influencing factors of patients with hypoalbuminemia and their relationship with clinical outcomes. We also compared the changes of particular laboratory indexes in patients with hypoalbuminemia before and after enteral nutrition therapy. RESULTS: A total of 482 patients were enrolled in the study. About 53.7% patients developed hypoalbuminemia during admission. Patients with hypoalbuminemia were older, had a higher proportion of combined diabetes mellitus, fever, dyspnea, and natriuresis, and had a relatively poorer prognosis than patients with normal albumin. Patients with hypoalbuminemia had higher levels of CRP, leukocytes, ALT, AST, total bilirubin, ALP, GGT, LDH, creatine kinase, D-dimer, globulin, and lower levels of lymphocytes and eosinophils. Severe, older, anorexia, elevated CRP, and decreased lymphocytes were the independent predictors for decreased albumin in COVID-19 patients. In addition, decreased albumin is correlated with adverse outcomes. Nutritional support therapy to correct serum albumin may improve patient outcomes. CONCLUSION: COVID-19 patients with hypoalbuminemia tend to have more severe clinical manifestations and more abnormal biochemical tests, which may result in poorer clinical outcomes. Nutritional support therapy may improve the clinical outcome of these patients.
format Online
Article
Text
id pubmed-8437137
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84371372021-09-14 Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis Chen, Chaoyue Zhang, Ying Zhao, Xi Tao, Meihui Yan, Wei Fu, Yu Infect Drug Resist Original Research BACKGROUND: Hypoalbuminemia has been reported in COVID-19 patients. Exploring the influencing factors and possible adverse consequences of albumin reduction may provide some guidance for the treatment of COVID-19 patients. METHODS: In this multicentre retrospective study, we collected information including demographics, comorbidities, clinical symptoms, complications, laboratory tests, treatment, and outcomes of patients diagnosed with COVID-19 from three hospitals in Wuhan, China. We compared the indexes between patients with hypoalbuminemia and normal albumin. Regression model was used to evaluate various influencing factors of patients with hypoalbuminemia and their relationship with clinical outcomes. We also compared the changes of particular laboratory indexes in patients with hypoalbuminemia before and after enteral nutrition therapy. RESULTS: A total of 482 patients were enrolled in the study. About 53.7% patients developed hypoalbuminemia during admission. Patients with hypoalbuminemia were older, had a higher proportion of combined diabetes mellitus, fever, dyspnea, and natriuresis, and had a relatively poorer prognosis than patients with normal albumin. Patients with hypoalbuminemia had higher levels of CRP, leukocytes, ALT, AST, total bilirubin, ALP, GGT, LDH, creatine kinase, D-dimer, globulin, and lower levels of lymphocytes and eosinophils. Severe, older, anorexia, elevated CRP, and decreased lymphocytes were the independent predictors for decreased albumin in COVID-19 patients. In addition, decreased albumin is correlated with adverse outcomes. Nutritional support therapy to correct serum albumin may improve patient outcomes. CONCLUSION: COVID-19 patients with hypoalbuminemia tend to have more severe clinical manifestations and more abnormal biochemical tests, which may result in poorer clinical outcomes. Nutritional support therapy may improve the clinical outcome of these patients. Dove 2021-09-09 /pmc/articles/PMC8437137/ /pubmed/34526790 http://dx.doi.org/10.2147/IDR.S327090 Text en © 2021 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Chaoyue
Zhang, Ying
Zhao, Xi
Tao, Meihui
Yan, Wei
Fu, Yu
Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis
title Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis
title_full Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis
title_fullStr Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis
title_full_unstemmed Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis
title_short Hypoalbuminemia – An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis
title_sort hypoalbuminemia – an indicator of the severity and prognosis of covid-19 patients: a multicentre retrospective analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437137/
https://www.ncbi.nlm.nih.gov/pubmed/34526790
http://dx.doi.org/10.2147/IDR.S327090
work_keys_str_mv AT chenchaoyue hypoalbuminemiaanindicatoroftheseverityandprognosisofcovid19patientsamulticentreretrospectiveanalysis
AT zhangying hypoalbuminemiaanindicatoroftheseverityandprognosisofcovid19patientsamulticentreretrospectiveanalysis
AT zhaoxi hypoalbuminemiaanindicatoroftheseverityandprognosisofcovid19patientsamulticentreretrospectiveanalysis
AT taomeihui hypoalbuminemiaanindicatoroftheseverityandprognosisofcovid19patientsamulticentreretrospectiveanalysis
AT yanwei hypoalbuminemiaanindicatoroftheseverityandprognosisofcovid19patientsamulticentreretrospectiveanalysis
AT fuyu hypoalbuminemiaanindicatoroftheseverityandprognosisofcovid19patientsamulticentreretrospectiveanalysis